In last trading session, RAPT Therapeutics Inc (NASDAQ:RAPT) saw 0.59 million shares changing hands with its beta currently measuring -0.06. Company’s recent per share price level of $8.43 trading at -$1.3 or -13.36% at ring of the bell on the day assigns it a market valuation of $139.40M. That closing price of RAPT’s stock is at a discount of -262.99% from its 52-week high price of $30.60 and is indicating a premium of 32.74% from its 52-week low price of $5.67. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.16 million shares which gives us an average trading volume of 107.40K if we extend that period to 3-months.
For RAPT Therapeutics Inc (RAPT), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.20. Splitting up the data highlights that, out of 6 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 3 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
RAPT Therapeutics Inc (NASDAQ:RAPT) trade information
Upright in the red during last session for losing -13.36%, in the last five days RAPT remained trading in the green while hitting it’s week-highest on Friday, 06/27/25 when the stock touched $8.43 price level, adding 14.33% to its value on the day. RAPT Therapeutics Inc’s shares saw a change of -65.79% in year-to-date performance and have moved 13.46% in past 5-day. RAPT Therapeutics Inc (NASDAQ:RAPT) showed a performance of 8.31% in past 30-days. Number of shares sold short was 0.75 million shares which calculate 6.54 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 33 to the stock, which implies a rise of 74.45% to its current value. Analysts have been projecting 2 as a low price target for the stock while placing it at a high target of 55. It follows that stock’s current price would jump 76.28% in reaching the projected high whereas dropping to the targeted low would mean a gain of 76.28% for stock’s current value.
RAPT Therapeutics Inc (RAPT) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -10.10% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 87.35% while estimates for its earnings growth in next 5 years are of 46.70%.
RAPT Therapeutics Inc (NASDAQ:RAPT)’s Major holders
Insiders are in possession of 0.42% of company’s total shares while institution are holding 99.42 percent of that, with stock having share float percentage of 99.84%. Investors also watch the number of corporate investors in a company very closely, which is 99.42% institutions for RAPT Therapeutics Inc that are currently holding shares of the company. FMR LLC is the top institutional holder at RAPT for having 5.24 million shares of worth $15.97 million. And as of 2024-06-30, it was holding 13.4704 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 3.11 million shares on 2024-06-30. The number of shares represents firm’s hold over 7.9972 of outstanding shares, having a total worth of $9.48 million.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 689.13 shares of worth $5.81 million or 0.52% of the total outstanding shares. The later fund manager was in possession of 180.05 shares on Mar 31, 2025 , making its stake of worth around $1.52 million in the company or a holder of 0.14% of company’s stock.
